z-logo
open-access-imgOpen Access
Reversal of Hypoxia in Murine Atherosclerosis Prevents Necrotic Core Expansion by Enhancing Efferocytosis
Author(s) -
Elke Marsch,
Thomas Theelen,
Jasper A. F. Demandt,
Mike L. J. Jeurissen,
Mathijs van Gink,
Robin Verjans,
Anique Janssen,
Jack P.M. Cleutjens,
Steven J.R. Meex,
Marjo M. P. C. Donners,
Guido R.M.M. Haenen,
Casper G. Schalkwijk,
Ludwig J. Dubois,
Philippe Lambin,
Ziad Mallat,
Marion J. Gijbels,
Johan W. M. Heemskerk,
Edward A. Fisher,
Erik A.L. Biessen,
Ben Janssen,
Mat J.A.P. Daemen,
Judith C. Sluimer
Publication year - 2014
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.114.304023
Subject(s) - carbogen , efferocytosis , hypoxia (environmental) , ldl receptor , tunel assay , terminal deoxynucleotidyl transferase , pathology , apoptosis , medicine , biology , endocrinology , chemistry , oxygenation , lipoprotein , cholesterol , in vitro , macrophage , oxygen , biochemistry , organic chemistry
Advanced murine and human plaques are hypoxic, but it remains unclear whether plaque hypoxia is causally related to atherogenesis. Here, we test the hypothesis that reversal of hypoxia in atherosclerotic plaques by breathing hyperoxic carbogen gas will prevent atherosclerosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom